BeOne Medicines Announced New Clinical Data From Its Breast Cancer Pipeline At The American Society Of Clinical Oncology Annual Meeting, Poster Presentations Feature Preliminary Results Of The Dose Escalation Studies Of: BG-C9074 For Advanced Solid Tumors